N-acetyl-seryl-aspartyl-lysyl-proline: A valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes

• Váldodahkkit: Keizo eKanasaki (Dahkki), Takako eNagai (Dahkki), Kyoko eNitta (Dahkki), Munehiro eKitada (Dahkki), Daisuke eKoya (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2014-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Fibroproliferative diseases are responsible for 45% of deaths in the developed world. Curing organ fibrosis is essential for fibroproliferative diseases. Diabetic nephropathy is a common fibroproliferative disease of the kidney and is associated with multiorgan dysfunction. However, therapy to comba...